# Glioma: Biomolecular Aspects

> **NCT05806619** · — · COMPLETED · sponsor: **Regina Elena Cancer Institute** · enrollment: 150 (actual)

## Conditions studied

- Glioma, Malignant

## Interventions

- **OTHER:** histopathological analysis; morphological and non-morphological magnetic resonance

## Key facts

- **NCT ID:** NCT05806619
- **Lead sponsor:** Regina Elena Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-22
- **Primary completion:** 2022-02-01
- **Final completion:** 2022-09-30
- **Target enrollment:** 150 (ACTUAL)
- **Last updated:** 2023-04-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05806619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05806619, "Glioma: Biomolecular Aspects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05806619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*